A Study To Evaluate An Oral Investigational Drug To See If It Helps Treat Symptoms In Adults With Adhd.
Posted Date: Jan 27, 2020
- Investigator: Caleb Adler
- Specialties: ADD/ADHD, Psychiatry/Psychology
- Type of Study: Drug
A Phase 3, Randomized, Double-blind, Multicenter, Placebo-controlled, Parallel-group Trial Evaluating the Efficacy, Safety, and Tolerability of Centanafadine Sustained-release Tablets in Adults with Attention-deficit/Hyperactivity Disorder (Trial 405-201-00014)
Criteria:
18 To 55 Years Of Age, Diagnosis Of Adhd
Keywords:
Adult, Add, Adhd
For More Information:
Emily Rummelhoff
513-558-4295
emily.rummelhoff@uc.edu